USADA Press Releases

USADA Press Releaseshttp://www.usantidoping.org/Current Press Releases for USADA May 15, 2012 The U.S. Anti-Doping Agency (USADA) announced today the launch of its new dietary supplement awareness website, Supplement 411 (<a href="http://www.supplement411.org">http://www.supplement411.org</a>), in an effort to meet the growing demand in the U.S. for accurate information, resources and guidance as potential consumers navigate the dietary-supplement marketplace. �The current marketplace has created a dilemma in which all athletes must balance their beliefs that these products provide a nutritional benefit, with the very real threat of the potential for dangerous health side-effects,� said USADA CEO Travis T. Tygart. Supplement 411 is the latest tool in a growing collection of resources including, publications, presentations, and online resources USADA provides to help parents, athletes, and athlete support personnel understand the risks associated with the use of dietary supplements and provide them the necessary information to make a healthy, informed decision. Supplement 411 provides an informational framework for understanding the issues surrounding dietary supplements, addressing important areas including: challenging the commonly held perceptions that dietary supplements are safe and effective; raising awareness of the risks in the dietary supplement marketplace; and providing guidance, resources and steps that can be taken to reduce risk as much as possible if an individual decides to use dietary supplements. USADA, along with other anti-doping entities, leagues and sport organizations around the world are often asked to provide definitive answers regarding dietary supplement product safety. �Education is key when making a choice whether or not to use a supplement. After checking out the new Supplement 411 website I got peace of mind from the 'Advanced Nutrition' section,� said Lauryn Williams Olympic medalist and World Champion sprinter, �Using reputable resources such as the Supplement 411 website can help you make the decision that is best for you.� Supplement 411 hopes to empower all athletes to make the best informed decision concerning supplement use. Supplement 411 will also list products that USADA has determined are of a higher risk to contain prohibited substances. The initial, and growing list, contains more than 100 products that either openly list ingredients on their labels, or have been tested and shown to contain substances, that are on the World Anti-Doping Agency (WADA) Prohibited List. USADA will update the list regularly. About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:askinner@usada.org">askinner@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- Supplement411- May 2012.pdfApril 27, 2012 USADA announced today that Jerry Shields of Jacksonville, Fla., an athlete in the sport of Paralympic archery, has tested positive for prohibited substances and has accepted a public warning for his anti-doping rule violation. Shields, 56, provided a urine sample on March 11, 2012, during an out-of-competition test, that resulted in an adverse analytical finding for Hydrochlorothiazide, Chlorothiazide, Triamterene and Labetalol. Hydrochlorothiazide, Chlorothiazide, Triamterene are in the class of diuretics and Labetalol is in the class of beta blockers prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the World Archery Federation (WA) anti-doping rules, both of which have adopted the World Anti-Doping Code (�Code�) and the World Anti-Doping Agency Prohibited List. Although the substances are prohibited under the applicable rules, an athlete who provides documentation in advance of competition, confirming the diagnosis of a valid medical need, may receive an exemption allowing the use of the substance. At the time of the test, Shields did not have an exemption to use the prohibited substances. After Shields provided his urine sample, he was granted a Therapeutic Use Exemption (�TUE�) by USADA. Under the applicable rules, athletes are to have obtained a TUE prior to using prohibited substances in order to avoid an anti-doping rule violation. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Shields - April 2012.pdfApril 20, 2012 USADA announced today that Jane Lock, of Colorado Springs, Colo., an athlete in the sport of Judo, has received a two-year suspension for committing an anti-doping rule violation in which she failed to file her whereabouts information. Lock, 24, is a member of the USADA National Testing Pool, which consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Lock failed to comply with the whereabouts requirements and, as a result, accrued three Whereabouts Failures within an 18-month period. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Judo Federation Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (�Code�), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation. A Whereabouts Failure for National Testing Pool athletes includes failure to provide required quarterly whereabouts filings and/or failure to be available for testing due to inaccurate or incomplete information provided by the athlete. Lock�s two-year period of ineligibility, began on April 20, 2012, the date she received the sanction. As a result of the violation, Lock has been disqualified from all competitive results achieved on and subsequent to January 1, 2012 the date of her third Whereabouts Failure, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: Annie Skinner, Media Relations Manager Phone: (719) 785-2046 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release-Lock- April 2012.pdfApril 16, 2012 USADA announced today that Patrick Mendes of Las Vegas, Nev., an athlete in the sport of weightlifting, has accepted a two-year suspension for his use of Human Growth Hormone (hGH). Mendes, 21, tested positive for hGH as the result of two separate samples collected on February 7, 2012, and February 27, 2012 as part of USADA�s Out of Competition Testing Program. The samples were tested at the WADA-accredited Sports Medicine Research & Testing Laboratory (SMRTL), located in Salt Lake City, Utah. Human Growth Hormone is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Weightlifting Federation (�IWF�) Anti-Doping Policies, both of which have adopted the World Anti-Doping Code. Mendes, admitted his use of hGH and accepted a two-year period of ineligibility, which began on March 19, 2012, the day he accepted a provisional suspension. As a result of the sanction, Mendes is also disqualified from all competitive results obtained on or subsequent to February 7, 2012, the date the first blood sample was collected, including forfeiture of any medals, points, and prizes. �This case demonstrates yet again that the hGH test works to stop this dangerous drug from being used in sport,� said USADA CEO Travis T. Tygart. �We are pleased the athlete in this case chose to admit his use of hGH and accept the sanction. USADA remains committed to detecting and deterring the use of this performance-enhancing drug so that all clean athletes can have confidence in the integrity of competition.� In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a>http://www.usada.org/files/active/resources/press_releases/Press Release-Mendes-April 2012 .pdfApril 13,2012 USADA announced today that Matt Kochem, of Somerset, N.J., an athlete in the sport of rowing, has accepted a one-year suspension for committing an anti-doping rule violation in which he failed to file whereabouts information. Kochem, 25, is a member of the USADA National Testing Pool, which consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Kochem failed to comply with the whereabouts requirements and, as a result, accrued three Whereabouts Failures within an 18-month period. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Rowing Associations (FISA) anti-doping rules, both of which have adopted the World Anti-Doping Code (�Code�), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation. A Whereabouts Failure for National Testing Pool athletes includes failure to provide required quarterly whereabouts filings and/or failure to be available for testing due to inaccurate or incomplete information provided by the athlete. Kochem�s one-year period of ineligibility, began on April 12, 2012, the date he accepted the sanction. As a result of the violation, Kochem has been disqualified from all competitive results achieved on and subsequent to January 21, 2012 the date of his third Whereabouts Failure, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.globaldro.com/">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release-Kochem- April 2012.pdfMarch 30, 2012 USADA announced today that Todd Robertson of Boulder, Colo., an athlete in the sport of cycling, has accepted a 15 month suspension for an anti-doping rule violation and his competitive results from November 1, 2009, have been disqualified. Robertson, 49, tested positive for a banned oxygen-enhancing peptide hormone as the result of a sample collected as part of USADA�s Out of Competition Testing Program on February 11, 2011. Oxygen-Enhancing Peptide Hormones are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code. Robertson�s 15 month period of ineligibility was reduced from the standard two-year period based on his providing Substantial Assistance under article 10.5.3 of the World Anti-Doping Code. Robertson began serving his sanction on February 14, 2011, while continuing to cooperate with USADA. As a result of the sanction, Robertson is also disqualified from all competitive results obtained on or subsequent to November 1, 2009, the date of his first use according to his admissions during the course of USADA�s investigation, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release-Todd Robertson- March 2012 .pdf March 7, 2012 Hundreds of high school age athletes participating in the New Balance Indoor Track & Field Championships hosted by the National Scholastic Sports Foundation, will be treated to a presentation by Dee Dee Trotter, a Track & Field Olympic gold medalist and Athlete Ambassador for the U.S. Anti-Doping Agency (USADA). Trotter will be speaking in the Auditorium at The New Balance Track & Field Center at The Armory in New York City, N.Y. on Friday, March 9, 2012 at 6:30 p.m. Trotter will share her experience as an Olympic Gold Medalist, and talk about the importance of fair play, clean sport and the life lessons she has learned as an athlete. She will also talk about her perspective on the impact of anti-doping programs and how important it is to have a level playing field in sport. Trotter, who participates in the USADA Athlete Ambassador program, is an outspoken advocate for clean competition and combating the use of performance-enhancing drugs in sport. Event Details: When: Friday, March 9, 2011 at 6:30 p.m. (media should arrive at 5:45 p.m. to get set up prior to the event starting at 6 p.m.) Where: The New Balance Track & Field Center at The Armory For directions to the facility please see: <a href="http://www.armorytrack.com/News/Category/Armory%20">http://www.armorytrack.com/News/Category/Armory </a> For further information about Dee Dee Trotter, or to schedule an interview with her regarding this engagement, please contact USADA Media Relations Manager, Annie Skinner at (719)785-2046 or <a href="mailto:askinner@usada.org%20">askinner@usada.org </a>. For more information about the New Balance Indoor Nationals please go to <a href="http://www.nationalscholastic.org/nbin">http://www.nationalscholastic.org/nbin</a> About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. http://www.usada.org/files/active/resources/press_releases/Press Release 2012 Dee Dee National Scholastic High School Indoor Track & Field Championships.pdfMarch 1, 2012 USADA announced today that Michael Rodgers of Hutto, Texas, an athlete in the sport of Track & Field, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Rodgers, 26, tested positive for methylhexaneamine (dimethylpentylamine), a stimulant, as a result of an in-competition urine sample collected at the Sport e Solidarieta event on July 19, 2011, in Lignano, Italy. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Rodgers accepted a 9-month period of ineligibility, beginning on July 19, 2011 the day his urine sample was collected. As a result of the sanction, Rodgers is also disqualified from any and all results obtained on and subsequent to July 19, 2011, including forfeiture of any medals, points, and prizes. Rodgers originally requested a hearing in front of independent American Arbitration Association (AAA) panel, at which he provided inaccurate and misleading testimony. However, before the false testimony was acted upon by the arbitration panel, Rodgers came forward, acknowledged the truth to the U.S. Anti-Doping Agency, recognized his responsibility and agreed to accept his sanction and to pay the full cost of the arbitration hearing. Rodgers provided independent corroborating evidence that his positive drug test resulted from the use of the supplement known as Jack3d several days prior to a competition. Jack3d has been implicated in positive tests involving several athletes and lists 1,3-Dimethylamylamine HCl on its label. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine (dimethylpentylamine). Athletes subject to the WADA Prohibited List should avoid supplements that reference methylhexaneamine, dimethylpentylamine, 1,3-Dimethylamylamine HCl, dimethylamylamine, geranium, geranamine, or geranium stems or which purport to come from geranium oil or any constituents of a geranium plant. USADA�s advisory can be found on the USADA website at <a href="http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.">http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.</a> In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Rodgers March 2012.pdf February 26, 2012 USADA announced today that an independent American Arbitration Association (AAA) arbitrator has issued a decision finding that Lenroy Thompson, of Lenexa, Kansas, a U.S. athlete in the sport of boxing, has committed an anti-doping rule violation and has received a one-year suspension for the offense. Thompson, 23, is a member of the USADA National Testing Pool, which consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Thompson failed to comply with the whereabouts requirements and, as a result, accrued three Whereabouts Failures within an 18-month period. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Boxing Association (AIBA) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (�Code�), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation. A Whereabouts Failure for National Testing Pool athletes includes failure to provide required quarterly whereabouts filings and/or failure to be available for testing due to inaccurate or incomplete information provided by the athlete. Thompson�s one-year period of ineligibility, began on February 25, 2012 the date the arbitrator issued the decision. As a result of the violation, Thompson has been disqualified from all competitive results achieved on and subsequent to November 9, 2011 the date of his third Whereabouts Failure, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.globaldro.com/">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="mailto:askinner@usada.org">media@usada.org</a> <a href="mailto:askinner@usada.org"></a> http://www.usada.org/files/active/resources/press_releases/Press Release- Thompson- February 2012.pdfFebruary 24, 2012 USADA announced today that an independent American Arbitration Association (AAA) arbitrator has issued a decision finding that Luis Arias, of Oak Creek, Wis., a U.S. athlete in the sport of boxing, has committed an anti-doping rule violation and has received a one-year suspension for the offense. Arias, 21, is a member of the USADA National Testing Pool, which consists of a select group of athletes subject to certain whereabouts requirements in order to be located for USADA Out-of-Competition testing. Arias failed to comply with the whereabouts requirements and, as a result, accrued three Whereabouts Failures within an 18-month period. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Boxing Association (AIBA) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (�Code�), the combination of three Whereabouts Failures within an 18-month period constitutes a rule violation. A Whereabouts Failure for National Testing Pool athletes includes failure to provide required quarterly whereabouts filings and/or failure to be available for testing due to inaccurate or incomplete information provided by the athlete. Arias� one-year period of ineligibility, began on February 24, 2012 the date the arbitrator issued the decision. As a result of the violation, Arias has been disqualified from all competitive results achieved on and subsequent to January 1, 2012, the date of his third Whereabouts Failure, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release-Arias- February 2012.pdfFebruary 3, 2012 �Unlike the U.S. Attorney, USADA�s job is to protect clean sport rather than enforce specific criminal laws. Our investigation into doping in the sport of cycling is continuing and we look forward to obtaining the information developed during the federal investigation.� CONTACT: Annie Skinner, Media Relations Manager Phone: (719) 785-2046 E-mail: <a href="mailto:askinner@usada.org">askinner@usada.org</a><a href="mailto:askinner@usada.org"> </a>http://www.usada.org/files/active/resources/press_releases/USADAStatement2.3.12.pdfFebruary 2, 2012 USADA announced today that an independent, three-member American Arbitration Association (AAA) panel has invalidated the competitive results of Eddy Hellebuyck, an athlete in the sport of Track & Field, from October 1, 2001 through January 30, 2004. Hellebuyck, 51, of Tucson, Ariz., tested positive for synthetic erythropoietin (EPO) in 2004 and received a two-year suspension. However, at the time of his initial suspension Hellebuyck denied he had ever intentionally used EPO. Recent information, including Hellebuyck�s own public admissions, revealed that his use of performance enhancing drugs dated back to 2001, directly contradicting the testimony he gave during his original anti-doping hearing. Based on this new evidence, the independent AAA panel ruled that all previous competitive results dating back to October 2001 should also be disqualified. Hellebuyck took the position that the statute of limitations prevented his past competitive results from being disqualified. However, the AAA Panel found the statute of limitations inapplicable due to Hellebuyck�s fraudulent conduct. �We are pleased the Panel has upheld the fundamental principle of fairness for clean athletes,� said USADA CEO Travis T. Tygart. �This decision sends a clear message that you can�t use performance enhancing drugs to cheat, conceal your violations, and when the truth is revealed, attempt to hide behind the statute of limitations.� The AAA decision is available on the USADA website at <a href="http://www.usada.org/arbitration-decisions/">http://www.usada.org/arbitration-decisions/</a> In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and psychoactive drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Hellebuyck - February 2012.pdfJanuary 13, 2011 USADA announced today that Nick Brandt-Sorenson of Los Angeles, Calif., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation. Brandt-Sorenson, 32, tested positive for Efaproxiral, which artificially enhances delivery of oxygen to the tissues, as the result of a sample collected at the Masters Road Nationals in Bend, Ore. Efaproxiral is prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code. Brandt-Sorenson accepted a two-year period of ineligibility, which began on September 4, 2011, the day his sample was collected. As a result of the sanction, Brandt-Sorenson is also disqualified from all competitive results obtained on or subsequent to August 31, 2011, the date the Masters Road Nationals event began, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release- Brandt-Sorenson- January 2012.pdfNovember 29, 2011 Qualified Candidates Invited to Apply to Serve as Athlete Director on USADA Board of Directors The United States Olympic Committee (USOC) Athlete Advisory Council is pleased to announce its nationwide application process by which qualified athlete candidates may be nominated to serve as an Athlete Member on the US Anti Doping Agency�s Board of Directors. A total of up to three candidates will be proposed to USADA�s Nominating Committee for their approval and acceptance for one of the two Athlete Member seats on USADA�s Board. The Athlete Director shall serve a four year term starting Fall of 2012 and may be reelected for an additional four years. Candidates should share the core values USADA: Integrity, respect, teamwork, responsibility, and courage. The role of Athlete Member on USADA�s Board shall entail advocating and protecting athletes� rights while remaining objective in achieving USADA�s goals. Candidates must have represented the United States in the Olympic, Pan American, Para Pan American, Paralympic Games, World Championships, or an event designated as an Operation Gold event within the ten (10) years preceding election. However, it is preferred that candidates have competed more recently than the 10 year rule. No candidate should have any prior doping violations and candidates may be required to complete and adequately pass a background and criminal check. The Anti Doping Division hopes to select from diverse pool of candidates from various backgrounds. Although a minimum of Bachelor�s Degree is a must, no specific degree is required. Knowledge of medicine, law, and chemistry may facilitate understanding of USADA policies and protocol. Athletes may come from any sport under the Olympic, Paralympic, Pan American or Para Pan American umbrella? Applicants must be persons of the highest personal and professional integrity who, in conjunction with other members of the Board, will collectively serve the long-term goals and interests of USADA. Applicant shall remain ethical and advocate for fair play and athletes� rights. All candidates must satisfy and abide by USADA�s Conflict of Interest Policy and must exhibit a level of independence, limiting their and their immediate family�s involvement in a financial or governance capacity with organizations in which USADA conducts doping controls. A copy of the Conflict of Interest policy is available upon request. Expected Time Commitments: <ul><li>USADA Board meets two to three times per year</li><li>USADA Board has occasional teleconferences</li><li>Each Directors is expected to serve on one to two sub-committees</li><li>The elected Athlete Director is expected to attend all scheduled AAC meeting.</li></ul> All Applications for nomination must be submitted by January 15th, 2012, and shall be submitted to BOTH Ashu Jain (<a href="mailto:usattathlete@gmail.com">usattathlete@gmail.com</a>) and Joanna Hayes (<a href="mailto:joannahayes76@aol.com">joannahayes76@aol.com</a>). Interested persons should submit the following: <ul><li>Cover letter summarizing qualifications, expertise, and willingness to serve starting Fall of 2012</li><li>Detailed Resume/Curriculum Vitae</li><li>Date of most recent Operation Gold event along with short-list of major international competitions and awards</li><li>Statement testifying that there have been no prior doping offenses or violations</li><li>Any potential conflicts of interest</li><li>Any governance positions held in the past (if any)</li><li>A recent picture is recommended however not required</li></ul> Tentative Timeline for Application Process: <ul><li>Application Deadline January 15th, 2012</li><li>Interview and Review Process January 16th � February 19th.</li><li>End of February or first AAC meeting of the year to ratify Subdivision�s nominations. If nominations are accepted, final candidates will be forwarded to USADA�s Nominating Committee by March 15th, 2012. 4-Year term begins Fall of 2012.</li></ul> http://www.usada.org/files/active/resources/press_releases/USADA Athlete Member on BOD Nomination announcement.pdfDecember 5, 2011 USADA announced today that Jessie Bates of Redondo Beach, Calif., an athlete in the sport of Taekwondo, has tested positive for a prohibited substance and accepted a suspension for her doping offense. Bates, 17, tested positive for methylhexaneamine, a stimulant, as a result of a urine sample collected at the Senior Nationals competition, on July 3, 2011, in San Jose, Calif. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the rules of the World Taekwondo Federation, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Bates accepted a sanction resulting in a 10-month period of ineligibility, beginning on July 3, 2011, the date the sample was collected. As a result of the sanction, Bates is also disqualified from all results obtained during the Senior Nationals, which began on June 28, 2011, as well as any other competitive results obtained subsequent to June 28, 2011, including forfeiture of any medals, points, and prizes. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine. That advisory can be found on the USADA website at <a href="http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.">http://www.usada.org/media/methylhexaneamine-and-dietary-supplements.</a> In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Bates December 2011.pdfNovember 29, 2011 USADA announced today that Damon Allen, Jr. of Philadelphia, Pa., an athlete in the sport of boxing, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Allen, Jr., 19, tested positive for Furosemide, a diuretic, as the result of an out-of-competition sample collected on July 19, 2011. Diuretics are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Boxing Association (AIBA) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Diuretics are listed as Specified Substances, and therefore the presence of those substances in an athlete�s sample can result in a reduced sanction. Allen, Jr. accepted a six-month period of ineligibility, which began on September 1, 2011, the day he accepted a provisional suspension. As a result of the sanction, Allen, Jr. is also disqualified from all results obtained on or subsequent to July 19, 2011, the day his urine sample was collected, including forfeiture of any medals, points and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a style="font-family: sans-serif;" href="http://www.GlobalDro.com%20">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Allen November 2011.pdfNovember 23, 2011 USADA announced today that Pamela Spuehler of Chula Vista, CA, an athlete in the sport of field hockey, has tested positive for a prohibited substance and accepted a suspension for her doping offense. Spuehler, 25, tested positive for Canrenone, a diuretic, as the result of an out-of-competition sample collected on September 14, 2011. Diuretics are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Hockey Federation (FIH) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Spuehler accepted a two-month period of ineligibility, which began on September 28, 2011, the day USADA received notice of the adverse finding, and will end on November 30, 2011. As a result of the sanction, Spuehler is also disqualified from all results obtained on or subsequent to September 14, 2011, the day her urine sample was collected, including forfeiture of any medals, points and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a>http://www.usada.org/files/active/resources/press_releases/Press Release- Spuehler November 2011.pdfNovember 18, 2011 USADA announced today that, Michael Diamond, of St. Augustine, Fla., an athlete in the sport of cycling, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to submit to a sample collection. On October 8, 2011, Diamond, 63, refused to submit a sample when notified by a doping control officer during an out-of-competition test. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete�s refusal to provide a sample when notified that he has been selected for doping control constitutes a rule violation. Diamond accepted a two- year period of ineligibility, which began on November 14, 2011 the day he accepted the sanction. As a result of the sanction, Diamond is also disqualified from all competitive results obtained on and subsequent to October 8, 2011, the date upon which he refused to submit to sample collection, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Diamond- November 2011.pdfNovember 17, 2011 USADA announced today that Nathaniel Tadd of Houston, Texas, an athlete in the sport of Taekwondo, has tested positive for a prohibited substance and received a suspension for his doping offense. Tadd, 20, tested positive for methylhexaneamine, a stimulant, as a result of a urine sample collected at the Senior Nationals competition, on July 3, 2011, in San Jose, Calif. Stimulants are prohibited under the USADA Protocol for Olympic Movement Testing and the rules of the World Taekwondo Federation, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Tadd received a two-year period of ineligibility, which began on November 16, 2011, the day he received his sanction. As a result of the sanction, Tadd is also disqualified from all results obtained during the Senior Nationals, which began on June 28, 2011, as well as any other competitive results obtained subsequent to June 28, 2011, including forfeiture of any medals, points, and prizes. USADA issued an athlete advisory on June 16, 2011 to make athletes aware of the concerns regarding methylhexaneamine. That advisory can be found on the USADA website at http://www.usada.org/media/methylhexaneamine-and-dietary-supplements. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Tadd November 2011.pdfOctober 27, 2011 USADA announced today that Frederic Kieser of Cleveland, OH, an athlete in the sport of track and field, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Kieser, 40, tested positive for methylhexaneamine, a stimulant, as a result of a sample collected at the USA Masters Track & Field Championships, in Berea, OH on July 28, 2011. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Kieser accepted an eight-month period of ineligibility, which began on September 22, 2011, the day he voluntarily withdrew from scheduled competitions pending the resolution of this matter. As a result of the sanction, Kieser is also disqualified from all results obtained during the USA Masters Track & Field Championships, which began on July 28, 2011, as well as any other competitive results obtained subsequent to July 28, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 Email: <a href="mailto:media@usada.org">media@usada.org</a> <div style="text-align: left;"> </div><span style="font-size:11.0pt;mso-bidi-font-size:10.0pt;line-height:115%; font-family:" frutiger="" lt="" 47="" lightcn","sans-serif";mso-fareast-font-family:calibri;="" mso-bidi-font-family:arial;mso-ansi-language:en-us;mso-fareast-language:en-us;="" mso-bidi-language:ar-sa"=""> <a href="mailto:media@usada.org"></a><span style="font-size:11.0pt;line-height:115%;font-family:" calibri","sans-serif";="" mso-fareast-font-family:calibri;mso-bidi-font-family:"times="" new="" roman";="" mso-ansi-language:en-us;mso-fareast-language:en-us;mso-bidi-language:ar-sa"=""><a href="mailto:askinner@usada.org"></a><span style="font-size: 11pt; line-height: 115%; font-family: sans-serif;" frutiger="" lt="" 47="" lightcn","sans-serif";="" mso-fareast-font-family:calibri;mso-bidi-font-family:arial;mso-ansi-language:="" en-us;mso-fareast-language:en-us;mso-bidi-language:ar-sa"=""> http://www.usada.org/files/active/resources/press_releases/Press Release- Kieser October 2011.pdfOctober 26, 2011 USADA announced today that Michael Miller of Morgantown, Pa, an athlete in the sport of cycling, has tested positive for a prohibited substance and accepted a suspension for his doping offense. Miller, 42, tested positive for methylhexaneamine, a stimulant, as a result of a sample collected at the Masters Track Nationals, on July 27, 2011, in Trexlertown, Pa. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Cycling Union (UCI) anti-doping rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete�s sample can result in a reduced sanction. Miller accepted an eight-month period of ineligibility, which began on September 2, 2011, the day he accepted a provisional suspension. As a result of the sanction, Miller is also disqualified from all results obtained during the Masters Track Nationals, which began on July 26, 2011, as well as any other competitive results obtained subsequent to July 26, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Manager Phone: (719) 785-2000 E-mail: <a href="http://media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release- Miller October 2011.docOctober 25, 2011 USADA announced today that Byron Duhon, of Elk Grove, Calif., an athlete in the sport of Track & Field, has accepted a two-year suspension for an anti-doping rule violation based on his refusal to comply with the sample collection process. Duhon, 53, refused to comply with the sample collection process for an in-competition doping control test on July 13, 2011 after being notified by a USADA Doping Control Officer at the World Masters Athletics Championships in Sacramento, Calif. Under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletics Federations (IAAF) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code, an athlete�s refusal to comply with the sample collection process when notified that he has been selected for doping control, constitutes a rule violation. Duhon accepted a two-year period of ineligibility, which began on October 21, 2011 the day he accepted his sanction. As a result of the sanction, Duhon is also disqualified from all results obtained during the World Masters Athletics Championships, which began on July 6, 2011, as well as any other competitive results obtained subsequent to July 6, 2011, including forfeiture of any medals, points, and prizes. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org">media@usada.org</a> http://www.usada.org/files/active/resources/press_releases/Press Release - Duhon - October 2011.pdf October 24, 2011 The U.S. Anti-Doping Agency (USADA) announced today that Dr. Richard W. Cohen has been named Chair of the organization�s Board of Directors. Cohen succeeds founding board member and previous Chair, Dr. Lawrence S. Brown, Jr., who is retiring after serving the organization for 11 years, including one as Chair. Cohen, who is also a member of USADA�s founding board, has served as Vice Chair since 2003. Joining Brown in retirement from the USADA Board of Directors, are Barry Axelrod and Dr. Andrew Mecca, both of whom have served the board since 2000. Both Axelrod, who served as the board�s Treasurer, and Mecca, are founding board members whose commitment and dedication to the organization�s growth have made a lasting impact on both the global anti-doping movement, as well as the countless athletes who compete fairly and clean. As part of this transition, USADA is also pleased to welcome new board members Dr. Richard Clark, Dr. Jim Kooler, John Bardis and Marcia Lee Taylor. These new board members bring a variety of expertise to the USADA board, including background in the medical field, knowledge of non-profit management, involvement with Olympic sport organizations, commitment to community engagement, familiarity with drug prevention and awareness, as well as an understanding of anti-doping programs. �Saying goodbye to three of our founding board members in Dr. Brown, Dr. Mecca and Mr. Axelrod is difficult considering their contributions in leading the organization from its start,� said USADA CEO Travis T. Tygart. �Their commitment and steadfast devotion to clean athletes and the integrity of sport has been an immeasurable part of growing USADA into one of the world leaders in the anti-doping community. Looking forward, we are assured of the organization�s continued success under the guidance of Dr. Cohen and enthusiastically welcome new board members Dr. Richard Clark, Dr. Jim Kooler, Mr. Bardis and Ms. Taylor.� With Cohen�s election to the position of Chair, current board member and Olympic great, Edwin Moses takes on the role as Vice Chair. Carl Swenson, a three-time Olympian and member of the USADA board since 2007, will serve as Treasurer, replacing Axelrod. Current USADA Board of Directors Richard W. Cohen, MD � Chair Edwin C. Moses � Vice Chair Annette Salmeen, DPhil - Secretary Carl Swenson - Treasurer John Bardis Richard Clark, MD, PhD Jean Fourcroy, MD, PhD, MPH Don L. Gambril Jim Kooler, DrPH Marcia Lee Taylor Richard W. Cohen, MD, Chair Dr. Richard Cohen is the current Chair of the Board of Directors and a founding member of the USADA Board. He became Vice Chair of the USADA Board in April 2003. He is a former member of the Doping Control Commission for both USA Weightlifting and the U.S. Bobsled and Skeleton Federation, and chaired the Atlanta Committee for the Olympic Games Doping Control Commission. Cohen is an orthopedic surgeon, and is a Medical Director and chair of both the Ethics Committee and the Adult Total Joint Restoration program at the Wellstar Health System in Atlanta. In addition he is a surveyor for The Joint Commission for Accreditation of Hospitals. New USADA Board of Director Members John Bardis John Bardis founded MedAssets in June of 1999, and has been the Company�s Chairman, President and Chief Executive Officer since its inception. Bardis has more than 25 years of experience in the healthcare industry. Beginning with American Hospital Supply and Baxter International, he held various senior management positions, including Vice President of the Baxter Operating Room Division and General Manager of the Eastern Zone. Bardis left Baxter in 1987 to join Kinetic Concepts. Kinetic Concepts, a NASDAQ traded company (KNCI) was the nation�s largest specialty bed and medical equipment rental company at the time of his departure as President in 1992. From 1992 to 1997, Bardis was President and CEO of TheraTx Inc, another NASDAQ traded company (THTX) which was a leading provider of rehabilitation services and operator of skilled nursing facilities. In 1995, TheraTx was named the second fastest growing public company in America by INC. Magazine, growing from $15mm to over $500mm in 5 years. Bardis was named Entrepreneur of the year by INC Magazine in 1995. Bardis graduated with a BS in Business from the University of Arizona. He serves on the board of USA Wrestling, the National governing body for amateur wrestling, is the founder of Hire Heroes USA and is Chairman of the Atlanta Fire Youth Hockey Club. Bardis was also named Team Leader of the U.S. Greco-Roman Wrestling Team for the 2008 Beijing Olympics and served as Team Leader in the 2007 World Championships where Team USA won the world team title for the first time in wrestling history. Richard Clark, MD, PhD Dr Richard V. Clark is with GSK Research and Development, Director of Discovery Medicine in the Metabolic Therapeutic Area. He received his MD and PhD at the University of Washington, Seattle, WA. Dr. Clark conducted clinical practice and research in Endocrinology and Metabolism at both Emory University and Duke University Schools of Medicine before joining GSK. He is a former president of the Andrology Society of America, and he was recently a guest editor for a special doping research issue of the journal Steroids. He has served on the USADA ADRB, has assisted with special case interpretations, and served as an expert witness. Marcia Lee Taylor Marcia Lee Taylor is the director of government relations for a national non-profit, The Partnership at Drugfree.org. Taylor worked as a staffer on Capitol Hill for 11 years and was the senior drug policy advisor on the Senate Judiciary Subcommittee on Crime and Drugs. During her time on Capitol Hill, Taylor worked on many important pieces of legislation including the Drug Addiction Treatment Act and the Anabolic Steroid Control Act of 2004. Jim Kooler, DrPH As the Administrator for the California Friday Night Live Partnership, Dr. Kooler provides leadership and support to 54 county Friday Night Live programs in California. He also leads the California Center for Youth Development and Health Promotion. From his office at the Tulare County Office of Education, with support from the State Department of Alcohol and Drug Programs, the Office of Traffic Safety and the Office of Problem Gambling, he leads the implementation of Friday Night Live, Club Live, Friday Night Live Kids, Friday Night Live Mentoring and the California Youth Council. He is the �Creative Wizard� for the Lifeplan Institute, Director of the Be The Change Movement with Challenge Day, and directing the creation of the California Mentoring Partnership. A strong ally to young people, Dr. Kooler has worked in the prevention field for 27 years. He previously was the Director of the Governor�s Mentoring Partnership and Deputy Director for the Prevention Services Division at the Department of Alcohol and Drug Programs. About USADA USADA is the non-profit, independent and non-governmental entity responsible for the testing and results management process in the U.S. for athletes in the Olympic and Paralympic Movement, upholding the Olympic ideal of fair play, and representing the interests of athletes. USADA is dedicated to preserving the integrity of sport through research initiatives and educational programs. The agency manages a drug reference phone hotline and Global Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as curricula, themed brochures and nutrition and dietary guides, easy-reference wallet cards for the prohibited substance list, periodic newsletters, and protocol and policy reference publications, all of which can be found at www.USADA.org. Contact USADA Media Relations Phone: (719) 785-2000 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - USADA BOD - October 2011.pdfOctober 21, 2011 USADA announced today that Joseph Papp, of Bethel Park, Pa., an athlete in the sport of cycling, has received an eight-year sanction for his second anti-doping rule violation. This non-analytical anti-doping rule violation is a result of Papp distributing banned performance-enhancing drugs on behalf of a Chinese drug distributor via the Internet for which he was also charged by the U.S. Attorney�s Office for violations of federal law. Papp pled guilty to two felony charges as a result. This is Papp�s second anti-doping rules violation as he tested positive for a prohibited substance and received a two-year sanction in May 2006. Papp, 36, received a reduction to an eight-year sanction in accordance with the rules since he has provided substantial assistance to anti-doping authorities, sharing information about ongoing criminal activity as well as potential anti-doping rule violations by athletes under USADA�s jurisdiction and/or the jurisdiction of other anti-doping organizations. As a result of USADA�s sanction, Papp was also disqualified from all competitive results obtained on and subsequent to January 1, 2007, including forfeiture of any medals, points, and prizes. Papp�s period of ineligibility began on September 1, 2007, the day he accepted a provisional sanction and began providing assistance under the rules, and will end on August 31, 2015. In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (<a href="http://www.GlobalDRO.com">www.GlobalDRO.com</a>), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation. USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs. CONTACT: USADA Media Relations Phone: (719) 785-2047 E-mail: <a href="mailto:media@usada.org%20">media@usada.org </a> http://www.usada.org/files/active/resources/press_releases/Press Release - Papp October 2011.pdfOctober 20, 2011 The Partnership for Clean Competition (PCC) today announced the PCC Fellowship Program, which aims to expand talent in the field of anti-doping research while also supporting high quality research. Through a formal selection process, the PCC Fellowship will support a qualified scientist at a leading university or nonprofit scientific institution who is interested in the field of anti-doping, who will undertake a meaningful project, and who demonstrates potential for long-term contribution to the anti-doping field. �The PCC Fellowship Program is an important step in eliminating the use of performance-enhancing drugs in sports,� said PCC Scientific Advisory Board Chairman Larry Bowers. �Attracting and developing high quality talent is vital to fostering new leadership in anti-doping science for the generations ahead.� Applications for the fellowship are due January 10, 2012 and applicants are required to have a PhD in a physical, biological, or medical science, or a pharmacology discipline. Candidates will need to demonstrate an excellent research and academic background and an interest in anti-doping, but may have limited specific experience with research in the field. The selected fellow will receive a $50,000 per-year stipend in each of the first two years. The WADA-accredited laboratory with which the applicant will collaborate or the fellow�s home institution is also eligible for funds to cover overhead. The PCC will select one fellow to participate in a two- to three-year program. During that time, the fellow will gain practical knowledge from a U.S.-based, WADA-accredited lab and use that knowledge to conduct research that supports the anti-doping field. The two labs participating in the first year of the program include the Sports Medicine Research and Testing Lab based in Salt Lake City, UT, and the UCLA Olympic Analytical Lab based in Los Angeles, CA. The final selection process will be carried out by the PCC Scientific Advisory Board, for which the criteria will include but not be limited to, the recommendations put forward by the WADA-accredited laboratories, the merits of the application and interview of the applicant, and the fit between the lab, the applicant and the proposed research topic. The final decision is anticipated by April 2012. To apply or to learn more about the PCC Fellowship, please visit the PCC website at www.cleancompetition.org. Please contact PCC President, Jill Zeldin, at (719) 866-3306 or jzeldin@cleancompetition.org with further questions. About the PCC The PCC is an innovative research collaborative founded by the U.S. Olympic Committee, United States Anti-Doping Agency, Major League Baseball and the National Football League, whose focus is to make targeted grants in support of non-partisan and independent scientific research. The PCC considers research that has a high likelihood of developing new methods and products that will advance the anti-doping field and ensure integrity in sport. Also participating and contributing financially to the PCC are the National Basketball Association, National Hockey League and the PGA Tour. For more information, please contact USOC Communications at (719) 866-4529 or visit <a href="http://www.cleancompetition.org%20">www.cleancompetition.org. </a> http://www.usada.org/files/active/resources/press_releases/